Aflac AFL Critical care — Deferred policy acquisition costs
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aflac in its filing.
Tagged under the XBRL concept us-gaap:DeferredPolicyAcquisitionCosts.
The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aflac's critical care — deferred policy acquisition costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aflac's critical care — deferred policy acquisition costs?
- Aflac (AFL) reported critical care — deferred policy acquisition costs of $1.35B in Q1 2026.
- How has Aflac's critical care — deferred policy acquisition costs changed year-over-year?
- Aflac's critical care — deferred policy acquisition costs increased by 0.4% year-over-year, from $1.35B to $1.35B.
- What is the long-term trend for Aflac's critical care — deferred policy acquisition costs?
- Over 2 years (2023 to 2025), Aflac's critical care — deferred policy acquisition costs has grown at a 1.0% compound annual growth rate (CAGR), from $5.29B to $5.4B.
- What does critical care — deferred policy acquisition costs mean?
- Represents the unamortized portion of costs directly associated with acquiring new insurance policies, such as commissions and underwriting expenses. These costs are capitalized and recognized as an expense over the life of the policy to match revenue recognition.